US Patent 7994171 Compounds for the treatment of hepatitis C
Patent 7994171 was granted and assigned to Bristol-Myers Squibb on August, 2011 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7994171 Compounds for the treatment of hepatitis C
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
